Cocrystal Pharma (COCP) Total Liabilities (2010 - 2026)

Cocrystal Pharma (COCP) has 16 years of Total Liabilities data on file, last reported at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 1.34% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (down 1.34% YoY), and the FY2025 full-year result was $3.4 million, down 14.04% from the prior year.
• Total Liabilities fell to $3.3 million in Q1 2026, from $3.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $4.9 million in Q4 2023 to a low of $1.3 million in Q4 2022.
• A 5-year average of $3.0 million and a median of $3.2 million in 2023 frame the typical range for Total Liabilities.
• Peak annual rise in Total Liabilities reached 282.95% in 2023, while the deepest fall reached 46.59% in 2023.
• Tracing COCP's Total Liabilities over 5 years: stood at $1.3 million in 2022, then jumped by 282.95% to $4.9 million in 2023, then slipped by 19.32% to $3.9 million in 2024, then declined by 14.04% to $3.4 million in 2025, then decreased by 2.1% to $3.3 million in 2026.
• Business Quant data shows COCP's Total Liabilities at $3.3 million in Q1 2026, $3.4 million in Q4 2025, and $2.8 million in Q3 2025.